Ortiz-Virumbrales, Maitane
Menta, Ramón
Pérez, Laura M.
Lucchesi, Ornella
Mancheño-Corvo, Pablo
Avivar-Valderas, Álvaro
Palacios, Itziar
Herrero-Mendez, Angel
Dalemans, Wilfried
de la Rosa, Olga
Lombardo, Eleuterio
Funding for this research was provided by:
European Union's Horizon 2020 Research and Innovation Programme (681031)
Takeda Pharmaceutical Company
Article History
Received: 23 December 2019
Accepted: 13 October 2020
First Online: 2 November 2020
Ethics approval and consent to participate
: Human samples were obtained after informed consent as approved by the Spanish Ethics Committee of reference for the site of tissue procurement (Hospital Nisa Prado de Aravaca, Clínica de la Luz Hospital, and transfusion center at Comunidad de Madrid, Madrid, Spain).
: Not applicable.
: All authors except WD are employees of Takeda.MO-V, PM-C, AA-V, OdlR, and EL are inventors on patents owned by Takeda.WD is a former employee of TiGenix and is an inventor on patents owned by Takeda.